Our study showed that, ICU treatments may be beneficial for the Covid-19 patients aged 80 years and older. Increased old age, high levels of CRP, PCT, ferritin, and having IMV are detected as poor outcome markers. As a result, we emphasize that ICU treatments should also be considered as an option for the elderly Covid-19 patients.
ACE: Angiotensin-converting enzyme; ALT: Alanine aminotransferase; Anti-IL-6 mAb: Anti-interleukin monoclonal antibody; AST: Aspartate aminotransferase; CAD: Coronary artery disease; COPD: Chronic obstructive pulmonary disease; COVID-19: Coronavirus disease 2019; CRP: C-reactive protein; CT: Computed tomography; DM: Diabetes Mellitus; FiO2: Fraction of inspired oxygen; HDF: Hemodiafiltration; HFNC: Nasal high flow cannula; HT: Hypertension; ICU: Intensive care unit; IMV: Invasive mechanical ventilation; IQR: Interquartile range; LDH: Lactate dehydrogenase; NIMV: Non-invasive mechanical ventilation; PaO2: Partial pressure of oxygen; PaCO2: Partial pressure of carbon dioxide; PCT: Procalcitonin; ROC: Receiver Operating Characteristic; SARS-CoV2: Severe acute respiratory syndrome coronavirus 2; WBC: White blood cell
Availability of data and materials
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
Ethics approval and consent to participate
This study was approved by the ethics committee of Şişli Hamidiye Etfal Training and Research Hospital with approval number 02.03.2021/1823 and waived the need for informed consent because of the retrospective design of the investigation. All methods were carried out in accordance with Declaration of Helsinki.
Consent for publication
BMC Anesthesiol. 2021;21(291) © 2021 BioMed Central, Ltd.